AROGA BIOSCIENCES Trademark

Trademark Overview


On Wednesday, January 28, 2026, a trademark application was filed for AROGA BIOSCIENCES with the United States Patent and Trademark Office. The USPTO has given the AROGA BIOSCIENCES trademark a serial number of 99620787. The federal status of this trademark filing is FINAL REFUSAL - MAILED as of Wednesday, July 8, 2026. This trademark is owned by Aroga Biosciences. The AROGA BIOSCIENCES trademark is filed in the Advertising, Business and Retail Services and Computer & Software Services & Scientific Services categories with the following description:

Non clinical writing services, namely, preparation of technical reports and summary documents; Publication writing, namely, preparation of non-clinical and clinical manuscripts, abstracts, posters, and scientific presentations; Regulatory writing, namely, assisting others with the writing of applications for new drugs for submission to government regulatory bodies; Providing technical support services, namely, regulatory submission management, in the nature of preparing regulatory documents for others, for electronic submission to regulatory authorities in the field of clinical research and pharmaceuticals; Providing project management services, namely, project management for others, for business purposes, in the fields of scientific and clinical research

Medical writing services, namely, clinical and non clinical writing services, namely, technical writing for others in the field of medicine; safety writing, namely, technical writing of voluntary safety standards for others in the field of medicine; chemistry writing, namely, technical writing in the field of medical chemistry; manufacturing writing, namely, technical writing of in the field of manufacture of medicines; controls writing, namely, software writing for others in the field of medicine; Providing technical support services in the nature of validation and authentication of data for others for regulatory documents for electronic submission to regulatory authorities in the field of clinical research and pharmaceuticals; Providing project management services for businesses in the fields of scientific and clinical research; Providing quality control services and quality assurance services, for others, in the field of medical and scientific research and regulatory compliance
aroga biosciences

General Information


Serial Number99620787
Word MarkAROGA BIOSCIENCES
Filing DateWednesday, January 28, 2026
Status645 - FINAL REFUSAL - MAILED
Status DateWednesday, July 8, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


NOT AVAILABLE"BIOSCIENCES"
Goods and ServicesNon clinical writing services, namely, preparation of technical reports and summary documents; Publication writing, namely, preparation of non-clinical and clinical manuscripts, abstracts, posters, and scientific presentations; Regulatory writing, namely, assisting others with the writing of applications for new drugs for submission to government regulatory bodies; Providing technical support services, namely, regulatory submission management, in the nature of preparing regulatory documents for others, for electronic submission to regulatory authorities in the field of clinical research and pharmaceuticals; Providing project management services, namely, project management for others, for business purposes, in the fields of scientific and clinical research
Goods and ServicesMedical writing services, namely, clinical and non clinical writing services, namely, technical writing for others in the field of medicine; safety writing, namely, technical writing of voluntary safety standards for others in the field of medicine; chemistry writing, namely, technical writing in the field of medical chemistry; manufacturing writing, namely, technical writing of in the field of manufacture of medicines; controls writing, namely, software writing for others in the field of medicine; Providing technical support services in the nature of validation and authentication of data for others for regulatory documents for electronic submission to regulatory authorities in the field of clinical research and pharmaceuticals; Providing project management services for businesses in the fields of scientific and clinical research; Providing quality control services and quality assurance services, for others, in the field of medical and scientific research and regulatory compliance

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateMonday, July 6, 2026
Primary Code035
First Use Anywhere DateWednesday, January 9, 2019
First Use In Commerce DateWednesday, January 9, 2019

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, January 28, 2026
Primary Code042
First Use Anywhere DateWednesday, January 9, 2019
First Use In Commerce DateWednesday, January 9, 2019

Trademark Owner History


Party NameAroga Biosciences
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121
US

Trademark Events


Event DateEvent Description
Wednesday, January 28, 2026NEW APPLICATION ENTERED
Wednesday, January 28, 2026APPLICATION FILING RECEIPT MAILED
Tuesday, May 26, 2026NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, May 27, 2026ASSIGNED TO EXAMINER
Wednesday, May 27, 2026NON-FINAL ACTION WRITTEN
Wednesday, May 27, 2026NON-FINAL ACTION E-MAILED
Wednesday, May 27, 2026NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, July 6, 2026TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, July 6, 2026CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, July 6, 2026TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, July 8, 2026FINAL REFUSAL WRITTEN
Wednesday, July 8, 2026FINAL REFUSAL E-MAILED
Wednesday, July 8, 2026NOTIFICATION OF FINAL REFUSAL EMAILED